Efficacy of HBV vaccination in children with thalassemia major, South Khorasan, Iran

Iranian Red Crescent Medical Journal

Volumn 11, Issue 3, 2009, Pages 318-320

  Azarkar, Zohre ^a   Sharifzadeh, G H R ^a  

^a BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anti HBS antibody; Iran; Thalassemia; Vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; IRAN; MALE; THALASSEMIA MAJOR; TREATMENT RESPONSE; VACCINATION;

EID: 67749135781     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sherlock Sh, Dooly J. Disease of the liver and billiary system in: Fauci A, Braunwald E, Kasper D, Hauser S, Iongo D, Jameson L, Loscalzo J: Harrison's principles of Internal Medicine, 16ed. New York: Mc GrawHiH; 2005.
2. Lancaster- Smith M. ABC of the upper Gastrointestinal tract. Gut 2003;52:615.
3. Abolghasemia H, Eshghi P. Comprehensive textbook of thalassemia. Iranian Pediatric Hematology & Oncology Society Publication 2005; pp. 235-6. (In Persian)
4. Daei Parizi MH, Kaffashan K. Determination of anti HBS antibody in serum level of thalassemic children between 1-4.5 years after 3 times HBS vaccination. Abstract Book of Pediatric News in Tehran Congress 1999; pp. 285-95. (In Persian)
5. Wright R, Millward-Sadler GH, Alberti KG. Liver and Billiary Disease. Philadelphia; WB Saunders Co. 1979; pp. 470-3.
6. Singh H, Pradhan M, Singh RL, Phadke S, Naik SR, Aggarwal R, Naik S. High frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusions. Vox Sang 2003; 84: 292-9. [12757503] [doi:10.1046/j.1423-0410.2003.00300.x]
7. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001;135:796-800. [11694104]
8. Vahidi AA, Varesvazirian M, Shamsadini A, Shamsadini S. Determination of hepatitis B surface antibody titer in vaccinated children with major thalassemia in Kerman-Iran. Iran J Immunol 2006;3:30-4.
9. Hepatitis Group. An Essay on durability of hepatitis B antibody in health services staff and the thalassemic patients, six years after vaccination in Sari. J Mazandaran Univ Med Sci 2001; 32:60-5. (In Persian)
10. Leonardi S, Leggio T, Sciacca A, Di Gregorio F, Musumeci S. Intradermal hepatitis B vaccination in thalassemia. Arch Dis Child 1990; 65: 527-9. [2141464] [doi:10.1136/adc.65.5.527]
11. Dentico P, Buongiorno R, Volpe A, Zavoianni A, De Mattia D, Sabato V. Long-term persistence of anti-HBs after hepatitis B immunization in thalassaemic patients. Infection 1992; 20:276-8. [1428184] [doi:10.1007/BF01710794]
12. Li H, Li RC, Liao SS, Yang JY, Zeng XJ, Wang SS. Persistence of hepatitis B vaccine immune protection and response to hepatitis B booster immunization. World J Gastroenterol 1998;4:493-496. [11819352]
13. Ayerbe MC, Pérez-Rivilla A; ICOVAHB group. Assessment of long-term efficacy of hepatitis B vaccine. Eur J Epidemiol 2001; 17:150-6. [11 599689] [doi:10.1023/A:1017922302854]
14. Simó Miñana J, Gaztambide Ganuza M, Fernández Millán P, Peña Fernández M. Hepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination. Vaccine 1996; 14:103-6. [8852404] [doi:10.1016/0264-410X(95)00176-2]